aLaboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology, Faculty of Medicine, University of Chile
bDepartment of Pharmacology, University of Extremadura. ARADyAL Instituto de Salud Carlos III, Cáceres. Spain
cNational Cancer Institute
dSan Juan de Dios Hospital
eUniversity of Chile Clinical Hospital
fFaculty of Life Sciences, Andrés Bello University
gInstitute of Population Health, Faculty of Medicine, University of Chile Santiago
hFaculty of Life Sciences, University of Tarapaca, Arica, Chile
Received 12 June 2018 Accepted 19 November 2018
Correspondence to Luis A. Quiñones, PhD, Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Carlos Shachtebeck 299, Quinta Normal, Santiago 8500000, Chile Tel: + 56 229 770 741/+ 56 2977 0744; e-mail: [email protected]